Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Dickman

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Current Opinion in Supportive and Palliative Care|February 18, 2011
Integrated strategies for the successful management of breakthrough cancer painAndrew Dickman
Current Opinion in Supportive and Palliative Care|May 31, 2022
New analgesics in cancer painElizabeth Farrer, Andrew Dickman
Palliative Medicine|June 17, 2004
NSAIDs: gastroprotection or selective COX-2 inhibitor?Andrew Dickman, John Ellershaw
Nursing Times|December 29, 2005
Use and practice implications of modified-release medicinesAndrew Dickman, Tina Carney
Current Opinion in Supportive and Palliative Care|January 31, 2025
Buprenorphine: an old dog with new tricksAi Deen Ng, Andrew Dickman
Journal of Pain and Symptom Management|December 5, 2003
Clonazepam as an adjuvant analgesic in patients with cancer-related neuropathic painHeino Hugel, John E Ellershaw, Andrew Dickman
Palliative Medicine|December 13, 2007
Use of nebulised adrenaline in the management of steroid-resistant stridorRuth J Flockton, Andrew Dickman, John E Ellershaw
Plos One|March 15, 2018
The current evidence base for the feasibility of 48-hour continuous subcutaneous infusions (CSCIs): A systematically-structured reviewJames Baker, Andrew Dickman, Stephen Mason, et al.
Clinical Medicine (London, England)|February 14, 2018
Updates in palliative care - overview and recent advancements in the pharmacological management of cancer painHelen Wood, Andrew Dickman, Angela Star, et al.
BMJ Supportive & Palliative Care|January 20, 2021
Anticipatory syringe pumps: benefits and risksBen Bowers, Kristian Pollock, Andrew Dickman, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Opinion in Supportive and Palliative Care|February 18, 2011
Integrated strategies for the successful management of breakthrough cancer painAndrew Dickman
Current Opinion in Supportive and Palliative Care|May 31, 2022
New analgesics in cancer painElizabeth Farrer, Andrew Dickman
Palliative Medicine|June 17, 2004
NSAIDs: gastroprotection or selective COX-2 inhibitor?Andrew Dickman, John Ellershaw
Nursing Times|December 29, 2005
Use and practice implications of modified-release medicinesAndrew Dickman, Tina Carney
Current Opinion in Supportive and Palliative Care|January 31, 2025
Buprenorphine: an old dog with new tricksAi Deen Ng, Andrew Dickman
Journal of Pain and Symptom Management|December 5, 2003
Clonazepam as an adjuvant analgesic in patients with cancer-related neuropathic painHeino Hugel, John E Ellershaw, Andrew Dickman
Palliative Medicine|December 13, 2007
Use of nebulised adrenaline in the management of steroid-resistant stridorRuth J Flockton, Andrew Dickman, John E Ellershaw
Plos One|March 15, 2018
The current evidence base for the feasibility of 48-hour continuous subcutaneous infusions (CSCIs): A systematically-structured reviewJames Baker, Andrew Dickman, Stephen Mason, et al.
Clinical Medicine (London, England)|February 14, 2018
Updates in palliative care - overview and recent advancements in the pharmacological management of cancer painHelen Wood, Andrew Dickman, Angela Star, et al.
BMJ Supportive & Palliative Care|January 20, 2021
Anticipatory syringe pumps: benefits and risksBen Bowers, Kristian Pollock, Andrew Dickman, et al.
Pageof 3